ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 570,20
-0,77%
Dow Jones
38 834,86
0,15%
DAX
18 067,91
-0,31%
Brent Oil
84,535
-0,19%
Bitcoin
65 216,98
0,38%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Regenerx Biopharmaceuticals (RGN)

  7. Regenerx Biopharmaceuticals (RGN) Actualités

RGN

Regenerx Biopharm In (RGN)

Regenerx Biopharmaceuticals
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:RGN
DateHeureSourceTitreSymboleSociété
22/12/201015h16Business WireFirst Patient Screened in Phase 2 Trial with RegeneRx’s RGN-259 for Dry Eye SyndromeAMEX:RGNRegenerx Biopharmaceuticals
21/12/201022h31Edgar (US Regulatory)Current report filing (8-K)AMEX:RGNRegenerx Biopharmaceuticals
20/12/201016h00Business WireRegeneRx’s Scientific Advisory Board Member Receives 2011 Camras AwardAMEX:RGNRegenerx Biopharmaceuticals
09/12/201016h51Business WireRegeneRx Receives Mexican Patent for the Use of TB4 for Prevention and Treatment of Cardiac DamageAMEX:RGNRegenerx Biopharmaceuticals
01/12/201016h30Business WireRegeneRx Receives Australian Patent Using TB4 to Protect Against Biological, Chemical and Toxic AgentsAMEX:RGNRegenerx Biopharmaceuticals
30/11/201019h41Business WireResearchers Identify Potential Thymosin Beta 4 ReceptorAMEX:RGNRegenerx Biopharmaceuticals
17/11/201015h35Business WireRegeneRx Receives Australian Patent Using Tβ4 for Treatment Of Gastrointestinal DisordersAMEX:RGNRegenerx Biopharmaceuticals
16/11/201020h30Business WireRegeneRx President and CEO to Present at Maxim Group Growth ConferenceAMEX:RGNRegenerx Biopharmaceuticals
12/11/201012h09Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:RGNRegenerx Biopharmaceuticals
02/11/201012h30Business WireRegeneRx Reports Positive Results of Preclinical Dry Eye StudyAMEX:RGNRegenerx Biopharmaceuticals
01/11/201021h30Business WireRegeneRx Receives Non-compliance Notice from NYSE Amex; Intends to Request HearingAMEX:RGNRegenerx Biopharmaceuticals
01/11/201017h56Business WireRegeneRx Awarded $733,438 from U.S. Government Under the Patient Protection and Affordable Care ActAMEX:RGNRegenerx Biopharmaceuticals
26/10/201017h07Business WireRegeneRx Announces Letter to Stockholders Posted on WebsiteAMEX:RGNRegenerx Biopharmaceuticals
14/09/201015h08Business WireRegeneRx Announces TB4 Stroke Study to be Honored at American Heart Association Scientific SessionsAMEX:RGNRegenerx Biopharmaceuticals
07/09/201016h35Business WireRegeneRx President and CEO to Speak at Rodman & Renshaw Annual Global Investment ConferenceAMEX:RGNRegenerx Biopharmaceuticals
03/09/201023h41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:RGNRegenerx Biopharmaceuticals
03/09/201023h22Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:RGNRegenerx Biopharmaceuticals
02/09/201013h00Business WireRegeneRx Appoints R. Don Elsey to Board of DirectorsAMEX:RGNRegenerx Biopharmaceuticals
20/08/201022h01Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:RGNRegenerx Biopharmaceuticals
02/08/201014h30Business WireBritish Researchers Report that TB4 is Essential to Heart DevelopmentAMEX:RGNRegenerx Biopharmaceuticals
21/07/201022h48Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (S-8)AMEX:RGNRegenerx Biopharmaceuticals
19/07/201018h30Business WireResearchers Report in Neuroscience that TB4 Improves Neurological Function after StrokeAMEX:RGNRegenerx Biopharmaceuticals
14/07/201019h12Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:RGNRegenerx Biopharmaceuticals
08/07/201014h30Business WireRegeneRx Awarded Australian Patent for New TB4 ApplicationsAMEX:RGNRegenerx Biopharmaceuticals
03/06/201017h10Business WireHenry Ford Study: Synthetic Peptide May Regenerate Brain Tissue in Stroke VictimsAMEX:RGNRegenerx Biopharmaceuticals
02/06/201022h05Business WireRegeneRx Announces Exercise of Over-Allotment Option for Recent Public OfferingAMEX:RGNRegenerx Biopharmaceuticals
01/06/201012h04Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:RGNRegenerx Biopharmaceuticals
01/06/201012h04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)AMEX:RGNRegenerx Biopharmaceuticals
25/05/201014h30Business WireAnnals of the New York Academy of Sciences Publishes Thymosin Beta 4 Research PapersAMEX:RGNRegenerx Biopharmaceuticals
24/05/201014h30Business WireResearchers Report Thymosin Beta 4 Significantly Reduces Damage from Traumatic Brain Injury & Improves Brain Function in Expe...AMEX:RGNRegenerx Biopharmaceuticals
 Showing the most relevant articles for your search:AMEX:RGN

Dernières Valeurs Consultées

NYSE
ALLY.PRBCL
Ally Financial Inc.
COIN
SOLOEUR
Sologenic
USOTC
BLMH
Blum (QB)
BOV
YBRA4
Ybyra Capital S.A PN
LATK
BNBUSDT
Binance Coin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés